Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

333.444
-4.541-1.34%
Number of Gainers:15
Number of Losers:31
Number of Flat:13
PE:- -
High:337.986
Open:337.986
Low:329.836
Close:337.986
Volume:87.29M
Turnover:3.21B
Market Cap:792.51B
Float Cap:688.80B

Loading ...

Citi Raises Keymed Bio Target Price to HK$97.5, Keeps Buy/High Risk Call

Deep News
·
Aug 23

Daiwa Raises KEYMED BIO-B Price Target to HK$110, Reaffirming Buy Call

Deep News
·
Aug 23

Keymed Biosciences Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.
·
Aug 22

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Reuters
·
Aug 22

Betterlife Holding Expects HY Loss of up to RMB 105 Million

Reuters
·
Aug 21

Massive Recall of Over 4 Million Vehicles Addresses Door Handle Safety Flaw That Could Hinder Emergency Escape

Deep News
·
Aug 21

Linklogis (SEHK:9959) Stock Rebounds As Profit Returns But Valuation Stays Rich

Simply Wall St.
·
Aug 21

China General Education Group Files Board, Committee Member List with Disclosure Responsibilities

Reuters
·
Aug 21

BetterLife Expects H1 Loss Attributable to Owners up to RMB 105 Million

Reuters
·
Aug 21

BetterLife Holding - Expects Loss of up to Rmb105 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS
·
Aug 21

BetterLife Holding - Expected Hy Profit Decrease Mainly Due to Lower Automobile Sales and Weak Market Sentiment

THOMSON REUTERS
·
Aug 21

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

Reuters
·
Aug 21

China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand

Reuters
·
Aug 21

Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating

Stock News
·
Aug 21

Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth

Reuters
·
Aug 21

Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges

Stock News
·
Aug 21

ZYLOXTB Surges Over 9% Intraday on Strong H1 Net Profit of 179 Million Yuan, Up 47.8% Year-On-Year

Deep News
·
Aug 21

China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses

Reuters
·
Aug 21

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

THOMSON REUTERS
·
Aug 21

Brii Biosciences: Hy Other Income Rmb19.5 Mln

THOMSON REUTERS
·
Aug 21